115 related articles for article (PubMed ID: 6155596)
1. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data.
Kast RE
Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596
[TBL] [Abstract][Full Text] [Related]
2. Cancer diagnostic test of Field and Caspary: Part I. Spontaneous aggregation of lymphocytes in saline suspension is blocked by albumin and histone in normals but not in various disease states: the lymphocyte aggregation blocking test.
Bjerrum OW; Kast RE
Med Hypotheses; 1980 Jan; 6(1):59-62. PubMed ID: 6991895
[TBL] [Abstract][Full Text] [Related]
3. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
5. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
8. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Cerni CH; Micksche M
Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
[TBL] [Abstract][Full Text] [Related]
9. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
10. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
Lewkonia RM; Kerr EJ; Irvine WJ
Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
[TBL] [Abstract][Full Text] [Related]
12. Determination of cell mediated immunity against tumour associated antigens in patients of ENT.
Nowak R; Günther M; Jenssen HL; Seyfarth M; Werner H; Putzke HP
Acta Otolaryngol; 1979; 87(3-4):400-3. PubMed ID: 87106
[TBL] [Abstract][Full Text] [Related]
13. Suppression by serum of immunoreactivity to a common tumour antigen in cancer patients.
Koppi TA; Khan JM; Halliday WJ
Oncology; 1984; 41(2):77-82. PubMed ID: 6200811
[TBL] [Abstract][Full Text] [Related]
14. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
15. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
Nakajima T; Chikamori M; Isojima K; Iwaguchi T
Gan; 1977 Aug; 68(4):449-57. PubMed ID: 80343
[No Abstract] [Full Text] [Related]
18. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
[TBL] [Abstract][Full Text] [Related]
19. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Glaves D; Harlos JP; Weiss L
Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
